Updating results

Bipolar disorder

Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart

NICE Pathway Published September 2014 Last updated February 2020

Epilepsy

Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

NICE Pathway Published January 2012 Last updated February 2020

Antenatal and postnatal mental health

Everything NICE has said on antenatal and postnatal mental health in an interactive flowchart

NICE Pathway Published November 2011 Last updated February 2020

Type 1 diabetes in adults

Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated February 2020

Asthma

Everything NICE has said on diagnosing, monitoring and managing asthma in children, young people and adults in an interactive flowchart

NICE Pathway Published March 2014 Last updated February 2020

Episcissors-60 for mediolateral episiotomy (MTG47)

Evidence-based recommendations on Episcissors-60 for mediolateral episiotomy

Medical technologies guidance Published February 2020

Antenatal and postnatal mental health: clinical management and service guidance (CG192)

This guideline covers recognising, assessing and treating mental health problems in women who are planning to have a baby, are pregnant, or have had a baby or been pregnant in the past year. It covers depression, anxiety disorders, eating disorders, drug- and alcohol-use disorders and severe mental illness (such as psychosis, bipolar disorder and schizophrenia). It promotes early detection and good management of mental health problems to improve women’s quality of life during pregnancy and in the year after giving birth.

Clinical guideline Published December 2014 Last updated February 2020

Bipolar disorder: assessment and management (CG185)

This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder.

Clinical guideline Published September 2014 Last updated February 2020

Epilepsies: diagnosis and management (CG137)

The guideline covers diagnosing, treating and managing epilepsy and seizures in children, young people and adults in primary and secondary care. It offers best practice advice on managing epilepsy to improve health outcomes so that people with epilepsy can fully participate in daily life.

Clinical guideline Published January 2012 Last updated February 2020

The percentage of women with epilepsy aged 18 or over and who have not attained the age of 45 who are taking antiepileptic drugs who have a record of being given information and advice about pregnancy or conception or contraception tailored to their pregnancy and contraceptive intentions recorded in the preceding 12 months

The percentage of women with epilepsy aged 18 or over and who have not attained the age of 45 who are taking antiepileptic drugs who have a record of...

General practice indicator suitable for use in the QOF Published February 2020

The percentage of women with schizophrenia, bipolar affective disorder or other psychoses under the age of 45 years who have been given information and advice about pregnancy, conception or contraception tailored to their pregnancy and contraceptive intentions recorded in the preceding 12 months.

The percentage of women with schizophrenia, bipolar affective disorder or other psychoses under the age of 45 years who have been given information...

General practice indicator suitable for use in the QOF Published February 2020

Leg ulcer infection: antimicrobial prescribing (NG152)

This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published February 2020

Leg ulcers

Everything NICE has said on leg ulcers in an interactive flowchart

NICE Pathway Published February 2020

Intrapartum care

Everything NICE has said on the care of healthy women and their babies during childbirth in an interactive flowchart

NICE Pathway Published November 2011 Last updated February 2020

Antimicrobial prescribing for common infections

Everything NICE has said on antimicrobial prescribing for common infections in an interactive flowchart

NICE Pathway Published October 2017 Last updated February 2020

Skin conditions

Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart

NICE Pathway Published March 2015 Last updated February 2020

Pressure ulcers

Everything NICE has said on preventing and managing pressure ulcers in all age groups in primary care and community settings in an interactive flowchart

NICE Pathway Published January 2012 Last updated February 2020

Foot care for people with diabetes

Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart

NICE Pathway Published May 2011 Last updated February 2020

Varicose veins in the legs

Everything NICE has said on diagnosing and managing varicose veins in the legs in an interactive flowchart.

NICE Pathway Published July 2013 Last updated February 2020

What is the most clinically and cost-effective conservative management for preventing diverticular disease in people with diverticulosis?

Recommendation ID NG147/2 Question What is the most clinically and cost-effective conservative management for preventing diverticular disease

Research recommendation Published February 2020

What is the clinical and cost effectiveness of CBD in epileptic disorders in children, young people and adults?

Recommendation ID NG144/3 Question What is the clinical and cost effectiveness of CBD in epileptic disorders in children, young people

Research recommendation Published February 2020

What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment for adults with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics?

Recommendation ID NG144/6 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

Research recommendation Published February 2020

What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment in babies, children and young people with chemotherapy-induced nausea or vomiting which persists with optimised conventional antiemetics?

Recommendation ID NG144/7 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

Research recommendation Published February 2020

What is the effectiveness and cost effectiveness of interventions to improve indoor air quality at home for people without pre‑existing health conditions?

Recommendation ID NG149/2 Question What is the effectiveness and cost effectiveness of interventions to improve indoor air quality at home

Research recommendation Published February 2020

What is the relative effectiveness and cost effectiveness of different oral fluids and different oral fluid regimens, both with and without oral N-acetylcysteine, at preventing contrast-induced acute kidney injury?

Recommendation ID NG148/2 Question What is the relative effectiveness and cost effectiveness of different oral fluids and different oral

Research recommendation Published February 2020

For adults with fibromyalgia or persistent treatment-resistant neuropathic pain, what is the clinical and cost effectiveness of cannabidiol (CBD), containing no, or traces of, delta-9-tetrahydrocannabinol (THC), as an add-on to standard treatment?

Recommendation ID NG144/1 Question For adults with fibromyalgia or persistent treatment-resistant neuropathic pain, what is the clinical

Research recommendation Published February 2020

Further evidence to address the uncertainties in the current clinical evidence,including the impact of gammaCore on all treatments and care as well as itslong-term benefits, would be welcome.

Recommendation ID MTG46/1 Question Further evidence to address the uncertainties in the current clinical evidence,including the impact

Research recommendation Published February 2020

What is the clinical and cost effectiveness of dosimetry-guided radioactive iodine strategies for hyperthyroidism?

Recommendation ID NG145/5 Question What is the clinical and cost effectiveness of dosimetry-guided radioactive iodine strategies for hyperthyroidism

Research recommendation Published February 2020

What are the clinically and cost-effective surgical approaches to managing complicated acute diverticulitis, including timing of surgery (elective or emergency)?

Recommendation ID NG147/5 Question What are the clinically and cost-effective surgical approaches to managing complicated acute diverticulitis

Research recommendation Published February 2020

What training, support or interventions help to reduce caring-related accidents or incidents?

Recommendation ID NG150/3 Question What training, support or interventions help to reduce caring-related accidents or incidents?

Research recommendation Published February 2020

What is the effectiveness of personal health and social care budgets in supporting carers to return to work, education or training?

Recommendation ID NG150/2 Question What is the effectiveness of personal health and social care budgets in supporting carers to return

Research recommendation Published February 2020

What is the cost effectiveness and safety of non-surgical ablation and stereotactic body radiotherapy compared to resection for people with metastatic colorectal cancer in the lung amenable to local treatment?

Recommendation ID NG151/1 Question What is the cost effectiveness and safety of non-surgical ablation and stereotactic body radiotherapy

Research recommendation Published February 2020

Which signs and symptoms (or combinations of signs and symptoms) predict a diagnosis of Kawasaki disease in children under 5 presenting with fever lasting 5 days or more?

Recommendation ID NG143/8 Question Which signs and symptoms (or combinations of signs and symptoms) predict a diagnosis of Kawasaki disease

Research recommendation Published February 2020

What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD spray for children, young people and adults with spasticity? In particular, what is the impact of spasticity on improvements in quality of life?

Recommendation ID NG144/5 Question What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD

Research recommendation Published February 2020

Does the addition of THC to CBD have an effect on seizure frequency, brain structure and neuropsychological performance when compared with both CBD alone and placebo in epileptic disorders in children, young people and adults?

Recommendation ID NG144/4 Question Does the addition of THC to CBD have an effect on seizure frequency, brain structure and neuropsychological

Research recommendation Published February 2020

What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism?

Recommendation ID NG145/11 Question What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism

Research recommendation Published February 2020

What are the emission profiles of indoor air pollutants released from building materials in a lived-in home environment?

Recommendation ID NG149/4 Question What are the emission profiles of indoor air pollutants released from building materials in a lived-in

Research recommendation Published February 2020

What information and support do people with diverticulosis, diverticular disease or acute diverticulitis need?

Recommendation ID NG147/4 Question What information and support do people with diverticulosis, diverticular disease or acute diverticulitis

Research recommendation Published February 2020

What is the health impact of exposure to individual air pollutants alone or combined with each other in the home?

Recommendation ID NG149/1 Question What is the health impact of exposure to individual air pollutants alone or combined with each other

Research recommendation Published February 2020

What interventions are effective and cost effective at raising awareness of the health risks of damp and mould in the home?

Recommendation ID NG149/5 Question What interventions are effective and cost effective at raising awareness of the health risks of damp

Research recommendation Published February 2020

What are the risk factors for diverticulosis progressing to diverticular disease?

Recommendation ID NG147/6 Question What are the risk factors for diverticulosis progressing to diverticular disease? Any explanatory

Research recommendation Published February 2020

Can risk of contrast-induced acute kidney injury be stratified by eGFR thresholds?

Recommendation ID NG148/1 Question Can risk of contrast-induced acute kidney injury be stratified by eGFR thresholds? Any explanatory

Research recommendation Published February 2020

The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled appointments are filled and the effect on patients' experience before and after the introduction of point-of-care (POC) creatinine devices to radiology departments.

Recommendation ID DG37/3 Question The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled

Research recommendation Published February 2020

The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for use across the NHS in people presenting for an outpatient CT scan with contrast agent is developed or an existing tool is validated.

Recommendation ID DG37/2 Question The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for

Research recommendation Published February 2020